Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Scinai Immunotherapeutics Ltd

SCNI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$3.22

▲ +9.52%

Market Cap $1.66M · Vol 43.10K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.66M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

62.15

Momentum

Beta

2.14

vs Market

52W High

$17.10

81.17% below

52W Low

$2.15

49.70% above

Volume

43.10K

Avg 6.60K

P/B

1.00

Price-to-book

ROE

N/A

Return on equity

Free Float

84.39%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Scinai Immunotherapeutics Ltd (SCNI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SCNI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+32.78%

+31.11%

-35.16%

-55.28%

YTD

-54.78%

-81.39%

-97.44%

-99.85%

Financials & Valuation

TTM · Annual

Total Revenue	$1.31M
Net Income	$-8,307,000.00
Revenue Growth (YoY)	-16.55%
Gross Margin	-202.29%
Operating Margin	-575.29%
Net Profit Margin	-633.64%
ROE	N/A
ROA · ROIC	-66.26% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.27
P/B	1.00
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	2.07B

Technical Indicators

50-Day SMA	$2.68
200-Day SMA	$6.41
RSI (14)	62.15
Beta	2.14
52-Week High	$17.10
52-Week Low	$2.15

Volume Today	43.10K
Avg Daily Volume (30D)	6.60K
Relative Volume	6.53x
Volatility (10D)	102.84
Volatility (30D)	88.58
Free Float	84.39%

Analyst Consensus

N/A

Current Price $3.22

Mean Target N/A

52W Low$2.15 52W High$17.10

Current

Target

$2.15 $17.10

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG007TGL3Q9

ISINUS09073Q3039

CountryIsrael

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LONN.S Lonza Group AG +1.09% ONC BeOne Medicines AG +1.44% RVMD Revolution Medicines Inc -1.07% 068270.KS Celltrion Inc -0.93% ABVX Abivax SA -2.75%

Company Profile

Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.